Drug intelligence / Profile preview

PHTPP

Development stage
Unknown
Modality
Small Molecules
Administration
Laboratory Use (in Vitro/in Vivo Only); Typically Administered In Cell Culture Or Animal Models Via Injection Or Gavage In DMSO/corn Oil, Not For Clinical Use[1][3][5]
01

Overview

PHTPP is a synthetic, nonsteroidal small molecule that acts as a highly selective antagonist of the estrogen receptor beta (ERβ), exhibiting approximately 36-fold selectivity for ERβ over estrogen receptor alpha (ERα)[2][3][5][7]. As a silent antagonist, it binds ERβ and blocks its functions in cellular assays and animal models, making it a valuable research tool for dissecting ERβ-specific biological processes and signaling pathways. Developed primarily as a research compound, PHTPP is not approved for human or veterinary use and is used exclusively in laboratory settings to investigate the role of ERβ in endocrinology, cancer, and neurobiology[3][5].

Other names
4-(2-phenyl-5,7-bis(trifluoromethyl)pyrazolo[1,5-a]pyrimidin-3-yl)phenol2-Phenyl-3-(4-hydroxyphenyl)-5,7-bis(trifluoromethyl)-pyrazolo[1,5-a]pyrimidine
02

Targets

ESR1 (ERα)ESR2 (ERβ)

Beyond the preview

Go deeper on PHTPP.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PHTPP.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call